Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials

Publication date: October 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 10Author(s): Per-Henrik Groop, Paresh Dandona, Moshe Phillip, Pieter Gillard, Steven Edelman, Johan Jendle, John Xu, Markus F Scheerer, Fredrik Thoren, Nayyar Iqbal, Enrico Repetto, Chantal Mathieu
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research